Shaina Smith, third from left, at the roundtable.

Shaina Smith, U.S. Pain director of State Advocacy & Alliance Development, was among several panelists who gathered July 20 in Concord, N.H., to discuss the findings of a draft report on abuse-deterrent formularies (ADFs), or pain medications that are formulated to be difficult to crush or tamper with. The draft report was released in May by the Institute for Clinical and Economic Review (ICER), a nonprofit that evaluates evidence on the value of medical tests, treatments, and innovations.

Read More